4C Medical Technologies, Inc.

About 4C Medical Technologies, Inc.

4C Medical Technologies, Inc. is dedicated to redefining solutions for mitral regurgitation by creating a new generation of minimally invasive technologies for structural heart disease. Their mission is to innovate in the field of heart disease treatment with advanced medical devices.

Products & Services

AltaValve™:A unique supra-annular Transcatheter Mitral Valve Replacement (TMVR) designed to expand the treatable patient population, streamline the procedure, and preserve critical cardiac structures. It is an investigational device limited to investigational use under U.S. federal law.

Specialties

Minimally Invasive Technologies Structural Heart Disease Transcatheter Mitral Valve Replacement (TMVR) Mitral Regurgitation Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D Preferred Stock Financing T: - FT: Series D Preferred Stock Financing	A: 175000000 MR: - FA: up to $175 million FAN: 175000000	D: 2025-03-05 FD: 2025-03-05	1 investors

Series D Preferred Stock Financing Latest

2025-03-05

$175.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Saravana Kumar

President, CEO & Board Member

K

Katherine (Yekaterina) Kumar

Chief Operating Officer

H

Harley Handegard

Chief Financial Officer

A

Adam Galloway

Vice President, Therapy Development

J

Jason Diedering

Vice President, R&D and Operations

R

Robert Parsons

Senior Director, Quality Assurance

View 8 more team members with Pro

Unlock Full Team Directory

Recent News